[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349439-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349439-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immunosuppressive-roles-of-pericytes-in-cancer-disease-insights-from-a-systematic-review-and-meta-analysis","Immunosuppressive roles of pericytes in cancer disease: insights from a systematic review and meta-analysis","","The systematic review examines poorly understood interactions between tumour-associated pericytes and the immune system, integrating evidence on functional roles, molecular mechanisms, biomarkers, and in vitro assessment methods. Using PRISMA-guided searches up to February 2026, 64 studies were analyzed and risk of bias was evaluated with OHAT and SYRCLE. Meta-analysis using UALCAN and TIMER shows pericytes shape an immunosuppressive tumour microenvironment by modulating multiple immune subsets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immunosuppressive-roles-of-pericytes-in-cancer-disease-insights-from-a-systematic-review-and-meta-analysis/349439/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immunosuppressive-roles-of-pericytes-in-cancer-disease-insights-from-a-systematic-review-and-meta-analysis/349439.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this systematic review?","Question",{"text":63,"@type":64},"It focuses on how tumour-associated pericytes interact with the immune system, including functional roles, mechanisms, biomarkers, and experimental assessment approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the studies selected and evaluated for bias?",{"text":68,"@type":64},"Literature searches were conducted in PubMed, Web of Science, and Scopus up to February 2026 following 2020 PRISMA guidelines. Risk of bias used OHAT for in vitro studies and SYRCLE for in vivo research.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the results indicate about how pericytes affect the tumour immune environment?",{"text":72,"@type":64},"Tumour-associated macrophages are highlighted as key regulators, while pericytes modulate many immune cell types, promoting an immunosuppressive tumour microenvironment and reducing traditional immunotherapy efficacy in experimental settings.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349439,1790420994,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Hernández-Camarero etal. Journal of Translational Medicine (2026) 24:861  \n[https://doi.org/10.1186/s12967-026-08216-9](https://doi.org/10.1186/s12967-026-08216-9)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nImmunosuppressive roles of pericytesin cancer disease: insights from a systematic review and meta-analysis  \nPablo Hernández-Camarero1,2*†, Belén Toledo2,3,8†, Ana Belén Díaz-Ruano 1,2†, Manuel Picon-Ruiz 1,2,6,7, Aitor González-Titos1,2, Roberto Madeddu3,4,5, Juan Antonio Marchal1,2,6,7 and Macarena Perán2,6,8*  \nAbstract  \nBackground Although the crosstalk between the immune system and tumour endothelial cells has been extensively investigated, interactions with tumour-associated pericytes (TAPs) remain poorly understood. Such issue may be of great interest considering the immunoregulatory roles of pericytes reported in both healthy and tumour tissues. This systematic review integrates current evidence on TAP–immune system interplay, encompassing functional roles, molecular mechanisms, associated biomarkers, and in vitro assessment methodologies. Preclinical investigations on the anticancer potential of TAP-targeted immunotherapies were also critically analysed, complemented by a metaanalysis assessing TAP-mediated immune regulation across distinct malignancies with a larger sample size.  \nMethods Following the 2020 PRISMA guidelines, literature searches were conducted in PubMed, Web of Science, and Scopus for studies published up to February 2026. Of 3,557 records, 64 met the inclusion criteria after multistage screening (“title and abstract,”“full text” and “reference check”) . Risk of bias was assessed using the OHAT tool for in vitro studies and the SYRCLE tool for in vivo research. Meta-analyses were performed using UALCAN and TIMER platforms.  \nResults Our findings identified tumour-associated macrophages (TAMs) as the main immune regulators of TAPs, while TAPs modulate a broad range of immune cells—including TAMs, dendritic cells, B and T lymphocytes, regulatory T cells, myeloid-derived suppressor cells, and natural killer cells—thereby promoting an immunosuppressive tumour microenvironment. Indeed, experimental studies demonstrate the capacity of TAPs to reduce the anti-tumour efficacy of traditional cancer immunotherapies like inhibitory immune checkpoint blockade or adoptive immune cells therapies. Evidence remains scarce for certain cancers (e. g., cholangiocarcinoma, hepatic, and head and necksquamous cell carcinoma) and for lymphatic TAPs. Marked heterogeneity among TAPs and the limited availability of commercial pericyte-like cell lines represent major experimental challenges. Immunotherapies targeting TAPs, such as  \n†Pablo Hernández-Camarero, Belén Toledo and Ana Belén DíazRuano contributed equally to this work.  \n*Correspondence:  \nPablo Hernández-Camarero[phernand@ujaen.es](phernand@ujaen.es)[ ](phernand@ujaen.es)Macarena Perán[mperan@ujaen.es](mperan@ujaen.es)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy","cbCaiozfiVIDWMTe","https://ap.wps.com/l/cbCaiozfiVIDWMTe","pdf",3978523,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n## Trial registration\n## Keywords\n# Introduction","[{\"question\":\"What is the main focus of this systematic review?\",\"answer\":\"It focuses on how tumour-associated pericytes interact with the immune system, including functional roles, mechanisms, biomarkers, and experimental assessment approaches.\"},{\"question\":\"How were the studies selected and evaluated for bias?\",\"answer\":\"Literature searches were conducted in PubMed, Web of Science, and Scopus up to February 2026 following 2020 PRISMA guidelines. Risk of bias used OHAT for in vitro studies and SYRCLE for in vivo research.\"},{\"question\":\"What do the results indicate about how pericytes affect the tumour immune environment?\",\"answer\":\"Tumour-associated macrophages are highlighted as key regulators, while pericytes modulate many immune cell types, promoting an immunosuppressive tumour microenvironment and reducing traditional immunotherapy efficacy in experimental settings.\"}]","Immunosuppressive roles of pericytes in cancer disease: insights from a systematic review and meta-analysis | PDF",1790083314,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e27e304b56d9d247d6ca2ba35d0efdc8.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f1a596983bce5bd3f8146bdc0871646.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b24d8ccb1c6afa06ba765789bc9dce7.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b44544f5d73daa20936dc8f7f8d5996.webp",980,1306]